In a decades-long effort, researchers have discovered how to tweak the molecular pathways that turn heart muscle motors up or ...
RIKEN researchers have discovered how right-handed molecules in our cells can give rise to cells that are not symmetrical ...
FDA approved CYTK's Myqorzo for oHCM. It reduces heart's pumping ability, has a warning for heart failure and expected to ...
After 27 years in business, Cytokinetics hopes to pit its own cardiac myosin inhibitor against one it initially developed—now owned by Bristol Myers Squibb—in a market worth billions. Aficamten has a ...
MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMFDA Approval Based on ...
Actin is a globular protein that is a major constituent of the cellular cytoskeleton. Actin can exist in monomeric form as G-actin (globular actin) or can form filaments (F-actin, filamentous actin) ...
This list is frequently updated as titles leave and join Netflix. *New additions are indicated with an asterisk. Netflix has made headlines by investing in highbrow dramas that win Oscars. But ...
Investor's Business Daily on MSN
Cytokinetics wins FDA approval for its first drug, taking on Bristol Myers
Cytokinetics won its first Food and Drug Administration approval late Friday, leading shares to jump in after-hours action.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback